| Media Release | 13 June 2017 |
Pharmaceutical research company Pharmaxis (ASX: PXS) today released a recording of a video interview with Chief Executive Officer Gary Phillips discussing the results of the pivotal Bronchitol® cystic fibrosis clinical trial for the US market reported earlier today and an update on the Pharmaxis business.
The ten minute video interview can be accessed via the following link:
https://www.youtube.com/watch?v=R0Rf6eWlCLM
SOURCE: Pharmaxis Ltd, Sydney, Australia
CONTACT: Felicity Moffatt, phone +61 418 677 701 or email felicity.moffatt@pharmaxis.com.au
| © Copyright 1996-2019 irasia.com Ltd. All rights reserved. |
|
DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any
information provided on this website. Under no circumstances shall irasia.com Ltd be liable
for damages resulting from the use of the information provided on this website.
TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited. TERMS OF USE: Please read the Terms of Use governing the use of our website. |